Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report on Form 10-K of EFT BioTech Holdings, Inc. (the “Company”) for the fiscal year ended March 31, 2009, I, Sharon Tang, the Chief Financial Officer (Principal Financial and Accounting Officer) of the Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
| 1. | Such Annual Report on Form 10-K for the year ending March 31, 2009 fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| | | |
| 2. | The information contained in such Annual Report on Form 10-K for the fiscal year ended March 31, 2009 fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: July 17, 2009
| /s/ Sharon Tang |
| Sharon Tang |
| Chief Financial Officer |
| (Principal Financial and Accounting Officer) |
